Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker INBX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 28, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 16, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 16, 2026 | INBX Inhibrx Biosciences, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 16, 2026 | INBX Inhibrx Biosciences, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jul 16, 2026 | INBX Inhibrx Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 15, 2026 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 15, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 3, 2026 | INBX Inhibrx Biosciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 14, 2026 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 11, 2026 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 11, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 21, 2026 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 21, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 19, 2026 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 16, 2025 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 16, 2025 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 14, 2025 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 23, 2025 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 23, 2025 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2025 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 28, 2025 | INBX Inhibrx Biosciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 14, 2025 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 1, 2025 | INBX Inhibrx Biosciences, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 17, 2025 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 21, 2025 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 21, 2025 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | INBX Inhibrx Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | INBX Inhibrx Biosciences, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 13, 2025 | INBX Inhibrx Biosciences, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 13, 2025 | INBX Inhibrx Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 14, 2024 | INBX Inhibrx Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2024 | INBX Inhibrx Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
37 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances